# CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions

> **NCT03214835** · NA · WITHDRAWN · sponsor: **CDx Diagnostics**

## Conditions studied

- Laryngeal Disease
- Laryngeal Tumor
- Laryngopharyngeal Reflux

## Interventions

- **DEVICE:** Endo CDx Brush biopsy

## Key facts

- **NCT ID:** NCT03214835
- **Lead sponsor:** CDx Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2018-02-01
- **Primary completion:** 2019-08
- **Final completion:** 2019-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Study halted prematurely, prior to enrollment of first participant.
- **Last updated:** 2020-07-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03214835

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03214835, "CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03214835. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*